Uthever NMN: Clinical Trial, Dose, Purity & What the Branded Ingredient Proves

Uthever is a branded β-NMN ingredient manufactured by EffePharm—not a finished supplement brand by itself. Its main advantage is traceability to a published 60-day randomized human trial and a defined ingredient identity. The important limitation is equally clear: a clinical trial on Uthever does not automatically validate every finished product that lists Uthever on the label.

Uthever NMN at a glance

Feature	Current information
What it is	Branded β-nicotinamide mononucleotide ingredient
Manufacturer	EffePharm
Published human RCT	Yes — Huang et al., 2022
Trial dose	300 mg/day
Trial duration	60 days
Randomized participants	Middle-aged and older adults; 66 completed/analysed in published report
Main signals	Directional NAD+/NADH, walking and questionnaire/metabolic changes; efficacy differences versus placebo were not statistically significant
Regulatory context	β-NMN NDI notification submitted by EffePharm in late 2025
What it does not prove	That every Uthever-containing retail formula reproduces the clinical trial

What does the Uthever name mean?

Uthever is EffePharm's branded NMN raw ingredient. Brands purchase the ingredient and formulate it into capsules, powders or combination products. That means there are two levels of evidence to evaluate:

• Ingredient-level evidence: identity, manufacturing specifications and published Uthever studies.
• Finished-product evidence: how much Uthever is in the bottle, batch potency, excipients, delivery system and quality control after manufacturing.

A product can use a credible branded ingredient and still require finished-product testing.

The 2022 Uthever randomized trial

The central human paper is Huang et al., a multicenter randomized double-blind placebo-controlled study in middle-aged and older adults. Participants received 300 mg/day NMN or placebo for 60 days. ^[1]

The study measured cellular NAD+/NADH, six-minute walking performance, insulin-resistance-related measures, SF-36 quality-of-life domains and safety outcomes.

What did the trial find?

The Uthever group increased its blood-cell NAD+/NADH value by 38% from baseline at day 60, compared with a 14.3% increase in the placebo group. The active group also showed favorable within-group or directional changes in six-minute walking distance, SF-36 scores and metabolic measures. ^[2]

The statistical caveat matters: the published paper states that the analysis found no statistically significant efficacy differences between the active and placebo groups. The between-group p value for the day-60 NAD+/NADH change was 0.40; the six-minute-walk difference was also not significant, and the HOMA-IR between-group difference was not significant.

That makes this trial useful as ingredient-specific human evidence, but much weaker as proof of efficacy than the frequently quoted “38% NAD increase” sounds in isolation. Uthever has a randomized human trial behind the ingredient; it does not have a randomized trial showing statistically significant anti-aging benefit versus placebo.

How strong is the Uthever trial?

Strength	Limitation
Randomized, double-blind, placebo-controlled	Relatively small sample
Multicenter design	Only 60 days
Defined branded ingredient	No long-term disease outcomes
Human NAD and functional endpoints	Between-group efficacy differences were not statistically significant
Commercially relevant dose	Does not validate higher-dose finished products automatically

The trial is useful precisely because it is human, randomized and ingredient-specific. But its lack of statistically significant between-group efficacy differences means it should be treated as a preliminary branded-ingredient trial—not as proof that Uthever itself produces established clinical benefits.

Does 300 mg Uthever prove 1,000 mg is better?

No. The Uthever RCT used 300 mg/day. Other NMN studies use 600, 900, 1,000 mg or more, but those are different formulations and protocols. A finished product containing 1,000 mg Uthever cannot claim its higher dose was directly validated by the 300 mg Uthever trial unless a specific 1,000 mg Uthever study supports that statement.

See our NMN dosage guide.

Was Uthever the product in the 2026 meta-analysis?

The 2026 NMN meta-analysis pools multiple NMN products and formulations rather than only Uthever. ^[3] Therefore its safety and metabolic conclusions support the broader NMN evidence base, not Uthever exclusively.

Uthever purity and manufacturing claims

EffePharm describes Uthever as high-purity β-NMN and publishes manufacturing/quality information on its official site. Uthever's current product page presents the ingredient as a defined branded source and links to its research library.

These are manufacturer claims. A finished supplement should still provide its own lot-specific documentation rather than relying only on the ingredient supplier's general specification.

Does branded NMN solve the fake-NMN problem?

It can improve traceability, but it does not eliminate the need to audit the final product. Independent published testing has found major label-claim failures in the wider NMN market. ^[4]

A manufacturer can accidentally underfill, substitute material, use an expired lot or fail to maintain stability even when the original raw material was legitimate.

β-NMN versus total NMN

Uthever is marketed specifically as β-NMN, which aligns with the form emphasized in clinical supplementation research. The 2026 isomer-analysis paper demonstrates why this level of specificity matters: commercial products can contain unexpected α-/β-NMN composition. ^[5]

Uthever and FDA regulatory status

EffePharm submitted a β-NMN new dietary ingredient notification in November 2025, after FDA reversed its earlier NMN drug-preclusion interpretation. The public FDA list records a response date in January 2026.

This is regulatory documentation, not FDA approval of anti-aging efficacy. See our updated NMN FDA-status guide.

Which brands use Uthever?

Current finished products that state they source Uthever include DoNotAge Pure NMN and ProHealth NMN Pro 1000. Our preferred Uthever-based NMN product is DoNotAge Pure NMN because it combines the named ingredient with a simple filler-free formula, flexible 500 mg unit dosing, current CoA access and stated every-batch independent testing.

Read our #1 DoNotAge NMN review and the ProHealth NMN review.

What Uthever's official marketing claims—and what the paper supports

The current Uthever website describes multiple research areas and presents the ingredient as supporting anti-aging functions. Its clinical-study page highlights NAD+/NADH, walking endurance and quality-of-life findings.

The peer-reviewed trial supports reporting that those outcomes were measured and that favorable directional changes occurred. It should also report that the efficacy comparisons versus placebo were not statistically significant. It does not demonstrate human lifespan extension or generalized reversal of aging.

Is Uthever the “best” NMN ingredient?

It has important advantages: branded identity, a published human RCT, current commercial use and regulatory documentation. Ingredient pedigree is only one part of a finished-product decision, which is why we also look at batch testing, formulation simplicity, dose flexibility and value. On that combined basis, DoNotAge Pure NMN is our current #1 NMN recommendation.

Our NMN buyer guide scores those dimensions separately.

Who might value Uthever most?

• Buyers who want a branded β-NMN source connected to a published human RCT.
• Consumers who prioritize traceable ingredient sourcing over anonymous bulk NMN.
• Researchers or reviewers who want to distinguish ingredient-level evidence from generic NMN.
• Brands that want a documented supplier rather than an unspecified NMN source.

What to verify on a Uthever finished product

• Does the label explicitly name Uthever and give the dose?
• Does the finished product have a batch-specific potency assay?
• Is the COA for the finished capsules/powder rather than only the raw material?
• Does the product add delivery claims not tested in the Uthever trial?
• Are benefits described at the same evidence level as the 60-day RCT?
• Is the price premium justified by transparency and dose rather than the trademark alone?

Related NMN guides

• DoNotAge Pure NMN review
• best NMN supplements
• NMN purity
• NMN human trials
• NMN dosage

Bottom line

Uthever has one of the stronger ingredient pedigrees in the NMN market because it connects a commercial β-NMN source to a published randomized human trial. That deserves credit. It is not a license for every Uthever-containing brand to claim clinically proven longevity, nor does it replace lot-specific finished-product testing.